The researchers noted, "Despite some sample size limitations, these instruments demonstrated varying degrees of internal ...

The oxygen-sensing protein HIF-1alpha may contribute to worsening pulmonary arterial hypertension (PAH) and is a possible ...

The American Lung Association is making strides to increase early diagnosis and treatment of pulmonary hypertension through ...

肺动脉高压（PAH）是一种罕见、进行性且危及生命的疾病，其特征是小肺动脉收缩和肺循环压力升高。其可导致患者的心脏负荷增加，严重限制了患者的体力活动，并可能导致心力衰竭和预期寿命缩短。资料显示，PAH患者的五年死亡率约为43%，所以探寻有效治疗方法是很 ...

A recent systematic review assessed the psychometric properties of various instruments for measuring QOL in patients with ...

IKT-001Pro For The Treatment Of Patients With Pulmonary Arterial Hypertension One of the main programs I wanted to go over from its pipeline would be the development of its c-Abl kinase targeting ...

Merck’s new pulmonary arterial hypertension (PAH) medication has posted another batch of promising clinical trial data, ...

Investors seemed to panic after the announcement, with a sell-off driving Keros' share price down 73%, reversing strong gains ...

Global Pulmonary Arterial Hypertension (PAH) Treatment Market is thriving due to a rising prevalence of pulmonary hypertension, advancements in drug development, increasing awareness about the disease ...

Keros Therapeutics said on Thursday it had paused giving patients higher doses of its high blood pressure treatment in a ...